儿童喘的遗传标记:对疾病过程变异的倾向
M V Smolnikova1, Ed W Kasparov1, M A Malinchik1
1Scientific Research Institute of Medical Problems of the North - a separate division of the Federal Research Center "Krasnoyarsk Science Center" of the Siberian Branch of the Russian Academy of Sciences, Krasnoyarsk, Russia.
Vavilovskii zhurnal genetiki i selektsii
|July 19, 2023
概括
细胞因子基因中的遗传标记与俄罗斯儿童的儿童喘严重程度有关. 特定的IL4,IL13,IL17A,IFNG和TNFA基因型影响喘的发展和控制,有助于个性化治疗策略.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 儿科 儿科 儿科
背景情况:
- 喘是一种复杂,昂贵的疾病,对儿童有很大的风险.
- 个性化治疗是控制喘严重程度和改善生活质量的关键.
- 遗传因素,特别是细胞因子基因多态性,与喘的发展有关.
研究的目的:
- 在俄罗斯患有喘的儿童中调查细胞因子基因多态的患病率.
- 识别与不同喘严重程度和控制水平相关的遗传标记.
- 为预防严重喘和优化个性化治疗提供公共卫生策略的信息.
主要方法:
- 实时PCR用于基因定型.
- 分析包括了以下细胞因子基因:IL2,IL4,IL5,IL6,IL10,IL12,IL13,IL17A,IL31,IL33,IFNG,TNFA. 在这些基因中
- 这项研究集中在俄罗斯克拉斯诺亚尔斯克地区的喘儿童身上.
主要成果:
- IL4 rs2243250 (CT基因型,T等位基因) 与整体和轻度/控制性喘相关.
- IL13 rs1800925 (TT基因型,T等位基因) 与严重/不受控制的喘有关.
- IL17A rs2275913 (AA基因型),IFNG rs2069705 (TT基因型) 和TNFA rs1800629 (A基因) 与轻度喘相关;IFNG rs2069705也与控制喘相关.
结论:
- 特定的细胞因子基因多态是儿童喘过程和严重程度的预测.
- 这些发现有助于了解俄罗斯人口的遗传倾向.
- 结果可以指导公共卫生倡议和个性化喘管理.
更多相关视频
相关概念视频
Asthma: Pathogenesis and Management
449
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
449
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Human Genetics
616
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
616
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
351
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
351


